YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Mallinckrodt to combine with Endo in $6.7B deal

Posted online

Drugmakers Mallinckrodt and Endo are set to combine.

The companies reached a cash-and-stock deal valued at $6.7 billion. Endo shareholders will receive $80 million in cash and own nearly 50% of the combined company. Mallinckrodt shareholders would own the remainder.

Mallinckrodt CEO Siggi Olafsson will lead the combined operation.

Read more from The Associated Press.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences